<DOC>
	<DOC>NCT02324309</DOC>
	<brief_summary>The study is designed to compare meal time glucose control associated with BIOD-531, a rapidly absorbed concentrated insulin to that associated with Humalog Mix 75/25 and Humulin R U-500 in patients with diabetes and severe insulin resistance.</brief_summary>
	<brief_title>BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin, Isophane</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<criteria>BMI &gt; 25 kg/m2 Diabetes Mellitus using ≥ 150 units of insulin or insulin analog per day and/or ≥ 100 units of insulin or insulin analog at a single dosing session for at least 1 month prior to screening HbA1c &lt; 10.0% History of bariatric surgery Corticosteroid therapy Significant cardiovascular or other major organ disease Females who are breast feeding or pregnant A sexually active person not using adequate contraceptive methods</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>